59 results
Page 2 of 3
6-K
EX-99.1
3kuvr ocgkqsq9kw
19 May 20
Annual and Extraordinary General Meeting of Shareholders
8:04am
6-K
EX-1.1
hc9rr
5 Mar 20
Report of Foreign Private Issuer
8:16am
424B5
t63i6q3g5yqo6zfudwpe
3 Mar 20
Prospectus supplement for primary offering
5:13pm
6-K
EX-1.1
n3knvnr
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
q9yb5klzn
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
lwrv 3d10
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
1e8303atk6rdt
20 Nov 19
Prospectus supplement for primary offering
4:46pm
6-K
EX-99.1
w5zfdgr9i0
14 Nov 19
Condensed Consolidated Financial Statements
7:30am
6-K
EX-99.1
4801b2g
26 Jul 19
Condensed Consolidated Financial Statements
4:32pm
424B3
6ockdvi
10 Jul 19
Prospectus supplement
8:18am
F-3
qdz9wgs6o gj
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
k8r1cbx
7 Jun 19
Shelf registration (foreign)
3:31pm